BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porter RJ, Murray GI, Brice DP, Petty RD, McLean MH. Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype. Br J Cancer 2020;122:545-54. [PMID: 31831860 DOI: 10.1038/s41416-019-0685-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Su C, Jia S, Ma Z, Zhang H, Wei L, Liu H, Theocharis SE. HMGB1 Promotes Lymphangiogenesis through the Activation of RAGE on M2 Macrophages in Laryngeal Squamous Cell Carcinoma. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/4487435] [Reference Citation Analysis]
3 Mittal SK, Abdo J, Adrien MP, Bayu BA, Kline JR, Sullivan MM, Agrawal DK. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review. J Gastrointest Oncol 2021;12:1197-214. [PMID: 34532080 DOI: 10.21037/jgo-21-117] [Reference Citation Analysis]
4 Jin S, Yang Z, Hao X, Tang W, Ma W, Zong H. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment. Biomark Res 2020;8:21. [PMID: 32551121 DOI: 10.1186/s40364-020-00201-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Porter RJ, Murray GI, Alnabulsi A, Humphries MP, James JA, Salto-Tellez M, Craig SG, Wang JM, Yoshimura T, McLean MH. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate. J Pathol Clin Res 2021;7:495-506. [PMID: 33988317 DOI: 10.1002/cjp2.222] [Reference Citation Analysis]
6 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
7 O’dowd D, O’sullivan J, Marcone S. Prognostic, Diagnostic and Predictive Biomarkers in the Barrett’s Oesophagus-Adenocarcinoma Disease Sequence. Cancers 2022;14:3427. [DOI: 10.3390/cancers14143427] [Reference Citation Analysis]
8 Flis E, Barber G, Nulty C, Keogh B, McGuirk P, Anand A, O'Sullivan J, Quante M, Creagh EM. Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett's and Oesophageal Adenocarcinoma Disease Progression. Cancers (Basel) 2021;13:2065. [PMID: 33922955 DOI: 10.3390/cancers13092065] [Reference Citation Analysis]